Intrinsic and Molecular Subtypes of Breast Cancer

This template was adapted from the original submission. Edits were made to enhance scientific accuracy, optimal usability and/or to meet industry-leading design standards for science communication. Breast cancer subtypes can be categorized based on their expression of hormone receptors (estrogen receptor (ER) and progesterone receptor (PR)), the proliferation marker Ki-67, and the receptor tyrosine kinase HER2. Targeted therapies, such as Herceptin (aimed at the HER2 protein) and Tamoxifen (aimed at the ER), can be used in the treatment of certain breast cancer subtypes. Prognosis varies based on the subtype of breast cancer.

Yes, you can customize this template with a free BioRender account (no credit card required). Paid plans unlock additional export formats, higher-resolution downloads, and publication permissions.

Yes, every element is fully editable. Icons, labels, colors, arrows, shapes and layout can all be changed to match your preferences or needs using BioRender's drag-and-drop editor. You can add or remove elements to fully customize your use case.

Yes, BioRender icons and templates meet journal, grant, and copyright standards for publication, and many researchers cite BioRender directly in their figure legends.

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Researchers and scientists use this template for publications, funding proposals, grant applications, presentations, posters, and more.